This is Chris from Withings, your new Moderator and "Official Voice" of Withings on this here Forum! Nice to meet you! :)
Today I'm sharing with you a letter from our CEO Mathieu Letombe regarding the recent ScanWatch delay. As we are focusing more on maintaining the Forum and providing faster answers for everyone here, we wanted to also have this message nested here so we're all on the same page.
It was originally shared with all KMI (Keep Me Informed) customers, but you can also find the letter permanently linked here:
Please check it out if you haven't already, and let us know how excited you are for the upcoming release! (I've pasted the letter in full below as well.)
" To our community,
Since our announcement at CES 2020 in Las Vegas, we have experienced unprecedented demand for ScanWatch, the world's most advanced health watch.
As you might expect, the exceptional health crisis we are all facing has impacted us in several ways, including:
• Conducting and finalizing clinical studies in order to respect study participants and the priorities of healthcare professionals
• Obtaining the certifications required to go to market
• Maintaining our production capacities
We’ve redoubled our efforts and are finally able to send you an update concerning its availability.
Most clinical studies have been successfully finalized. A first study validated that ScanWatch is able to detect atrial fibrillation via ECG recording or via an optical sensor (PPG). A second study also validated that ScanWatch is able to deliver a medical-grade SpO2 measurement. The third study, which was paused during the health crisis, concerns sleep apnea detection and has now resumed.
Certifications & availability
We have received CE medical certification, allowing ScanWatch to go on the market in Europe. This is why, in Europe, ScanWatch will be fully available on withings.com and on our trusted retail partner channels in September 2020 following the return to our normal production capacities. This summer, an initial launch with limited quantities will be available for users in Europe. This initiative will offer users in Europe who have registered on withings.com/scanwatch the opportunity to order and receive a ScanWatch in advance.
In the US, we have not yet received FDA clearance. We are doing everything we can to facilitate FDA clearance and will be able to offer ScanWatch to you as soon as possible. We expect to offer it in fall 2020. We will communicate a more precise time frame when we have more information.
Whether you are in Europe or in the US, and whether you’ve been a customer for years or are new to Withings, we are sincerely looking forward to sharing our latest innovation to help you keep track of your health.
On behalf of the entire team, thank you for your patience, support, and trust in Withings to help you on the journey to better health.